Bonus27 Apr 2026, 07:51 pm
Aptus Pharma declares 3:2 bonus, approves FY26 results
AI Summary
Aptus Pharma's Board of Directors approved the Audited Financial Results for the half year and financial year ended March 31, 2026, with an unmodified audit opinion. Concurrently, the company announced a bonus share issue in the ratio of 3:2 (three equity shares for every two existing shares). Tuesday, May 12, 2026, has been fixed as the Record Date for determining eligible shareholders for the bonus shares. The bonus shares will be credited to eligible shareholders as per applicable laws.
Key Highlights
- Board approved Audited Financial Results for FY26.
- Auditors issued an unmodified opinion on FY26 results.
- Company declared a 3:2 bonus share issue.
- May 12, 2026, set as Record Date for bonus shares.